Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-8.32	62.03	67.66
Graham Fair Price	46.39	9.28	6.34
PEG	-88.63	0.83	-7.27
Price/Book	-36.02	34.92	54.58
Price/Cash Flow	21.71	98.27	80.74
Prices/Earnings	-19.69	25.66	31.96
Price/Sales	-2.28	22.58	23.11
Price/FCF	21.71	98.27	80.74
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	2.36	0.73	0.71
Operating Margin	20.94	0.34	0.28
ROA	27.29	0.02	0.02
ROE	0.43	0.34	-20.33
ROIC	0.03	0.04	25.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.01	< 0.005	-38.59
Dividends QOQ	< 0.005	< 0.005	24.84
EBIT QOQ	0.04	0.30	751.92
EPS QOQ	-0.04	0.31	606.03
FCF QOQ	5.06	-0.14	-97.30
Revenue QOQ	0.03	0.08	189.47
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	49.45	49.60	0.30
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.94	0.90	-3.84
Quick Ratio	0.69	0.59	-14.99
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2.05	3.36	64.01
Cash	3.60	3.87	7.45
Capex	-0.61	-1.02	-66.84
Free Cash Flow	1.38	1.19	-13.78
Revenue	4.83	5.19	7.39
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.85	0.72	-15.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.78	11.88	-13.81
Naive Interpretation	Member

06 - Financial Health · Bad

Rating